IBD Patients Who Miss Biologics Just Four Days at Increased Flare Risk
Little is known about the optimal level of adherence in patients with inflammatory bowel disease (IBD) on biologic therapy and for IBD patients using biological therapy, non-adherence leads to anti-drug antibody formation and reduced effectiveness, according to lead investigator Shail…